NCT04481698View on ClinicalTrials.gov

Mesoglycan for Pain Control After Open Excisional HAEMOrrhoidectomy

CompletedOBSERVATIONAL
Enrollment

398

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
Haemorrhoidal DiseasePost-operative PainThrombosis
Interventions
OTHER

Mesoglycan

Prisma® 30 mg 2 vials i.m./day for the first 5 post-operative days and then Prisma® 50 mg 1 oral tablet twice/day for an additional 30 days

Trial Locations (1)

88100

University of Catanzaro, Catanzaro

All Listed Sponsors
collaborator

Gaetano Gallo

UNKNOWN

collaborator

Giuseppe Sammarco

UNKNOWN

collaborator

Giuseppe Clerico

UNKNOWN

collaborator

Alessandro Sturiale

UNKNOWN

collaborator

Michele Manigrasso

UNKNOWN

collaborator

Alberto Realis Luc

UNKNOWN

collaborator

Mario Trompetto

UNKNOWN

lead

Societa Italiana di Chirurgia ColoRettale

NETWORK

NCT04481698 - Mesoglycan for Pain Control After Open Excisional HAEMOrrhoidectomy | Biotech Hunter | Biotech Hunter